The University of Michigan baseball team will host rival Michigan State on May 7 at 6 p.m. in the inaugural Strikeout ALS Game, presented by Michigan Medicine’s ALS Center of Excellence.
After losing her mother to Alzheimer's disease, Dr. Eva Feldman has led the way in developing new stem cell treatments.
Michigan Medicine researchers identify a potential therapeutic target for neurodegenerative conditions using models.
Dr. Stephen Goutman reviewed his recent ALS research on<br> Michigan Radio’s Stateside program. His latest findings<br> examined how environmental toxins impact ALS progression.
In a new study, lead author Dr. Amy Rumora and senior author Dr. Eva Feldman observed a reversal of chronic nerve damage with the consumption of unsaturated dietary fats.
Swapping dietary saturated fats for monounsaturated fats reverses nerve damage and restores nerve function in male mice, shows newly published research in the Journal of Neuroscience.
The Detroit Free Press featured Dr. Eva Feldman, Dr. Stephen Goutman, patient Rob Cotton, and Lisa Cotton in its story on the role of pesticides and pollutants in ALS.
A new study helps determine the role of pesticides and pollutants during the course of the progressive neurodegenerative disease that has no cure.
As a Michigan representative in the United States Congress for nearly 60 years, John Dingell's dedication to improving health care across the country has and will continue to pay dividends for decades to come. was a significant supporter of medical research, including the work that takes place in the PNR&D laboratory.
Tauber Family Interns spend 10 weeks in the laboratory to assist research on amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, and neurological complications related to diabetes.
Lucy Hinder, Ph.D., served as the PNR&D team lead for diabetic neuropathy research. During her 10 years in the laboratory, she produced 19 peer-reviewed manuscripts, one book chapter and one electronic article.
Catrina Sims-Robinson, Ph.D., who was a postdoctoral fellow and research investigator for the Program for Neurology Research & Discovery from 2008-14, is currently an assistant professor of neurology at the Medical University of South Carolina.
Charlene Handleman’s $150,000 contribution will support a junior faculty member researching Alzheimer’s disease.
